Literature DB >> 2035440

Reactivity of proximal and distal angiographically normal and stenotic coronary segments in chronic stable angina pectoris.

D Tousoulis1, J C Kaski, P Bogaty, F Crea, S Gavrielides, A R Galassi, A Maseri.   

Abstract

To assess whether vasoreactivity of significant coronary stenosis (greater than 50% intraluminal diameter reduction) and that of angiographically normal coronary segments differs in proximal and distal locations, 53 patients (40 men, 13 women, mean +/- standard deviation age 55 +/- 11 years) with chronic stable angina and angiographically documented coronary artery disease were studied. While abstaining from antianginal therapy, all 53 patients underwent coronary arteriography before and after 1 mg of intracoronary isosorbide dinitrate and 21 of the 53 also before and after 20 to 30 micrograms intracoronary ergonovine. Computerized quantitative angiography was used to assess changes in the intraluminal diameter of 126 normal coronary segments (63 proximal, 63 distal) and 43 significant coronary stenoses. Nitrates dilated proximal normal coronary segments by 7.4 +/- 1.2% and distal normal coronary segments by 15 +/- 1.7% (p less than 0.01). Significant proximal coronary stenoses dilated by 11 +/- 2.5% and distal stenoses by 23 +/- 2.8% (p less than 0.01) after nitrates. Ergonovine reduced the diameter of proximal normal coronary segments by 9.3 +/- 1.7% and that of normal distal segments by 15.5 +/- 1.4% (p less than 0.01). Proximal stenoses constricted by 11 +/- 2.2% and distal stenoses by 18.4 +/- 2.8% (p = 0.06). Analysis of segments showed that nitrates dilated 19 of 63 (30%) proximal normal segments by (greater than or equal to 10%), 31 of 63 (49%) distal (p less than 0.05) and 21 of 43 (49%) stenoses.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2035440     DOI: 10.1016/0002-9149(91)90926-c

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries.

Authors:  D Tousoulis; G J Davies; C Tentolouris; T Crake; G Goumas; C Stefanadis; P Toutouzas
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

2.  Effects of L- and D-arginine on the basal tone of human diseased coronary arteries and their responses to substance P.

Authors:  D Tousoulis; C Tentolouris; T Crake; G Katsimaglis; C Stefanadis; P Toutouzas; G J Davies
Journal:  Heart       Date:  1999-05       Impact factor: 5.994

3.  Evidence of partially preserved endothelial dilator function in diseased coronary arteries.

Authors:  D Tousoulis; C Tentolouris; T Crake; C Stefanadis; P Toutouzas; G Davies
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

4.  Variable coronary vasomotor responses to acetylcholine in patients with normal coronary arteriograms: evidence for localised endothelial dysfunction.

Authors:  D Tousoulis; G Davies; D C Lefroy; A W Haider; T Crake
Journal:  Heart       Date:  1996-03       Impact factor: 5.994

Review 5.  Management of vasospastic angina--role of nicorandil.

Authors:  J C Kaski
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.